JB/CALL/POLE GROU/22/0.125/20.12.24 | Market Closed - Swiss Exchange 08:50:00 14/06/2024 pm IST | ||
| 1.58 CHF | +1.28% |
|
| 1 month | -3.07% | ||
| 3 months | +143.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.58 | +1.28% |
| 13/24/13 | 1.56 | -3.11% |
| 12/24/12 | 1.61 | -1.23% |
| 11/24/11 | 1.63 | +5.16% |
Delayed Quote Swiss Exchange
Last update June 14, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPGOJB | |
| ISIN | CH1276780074 |
| Date issued | 21/07/2023 |
| Strike | 22 CHF |
| Maturity | 20/12/2024 (188 Days) |
| Parity | 8 : 1 |
| Emission price | 0.61 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.69 CHF |
|---|---|
| Lowest since issue | 0.17 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.63% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
34.46
EUR
Average target price
25.12
EUR
Spread / Average Target
-27.09%
- Stock Market
- Warrants
- PPGOJB Warrant
